Best Biomarker Practice (BBP) Guidelines

Publications

• Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycin.
  Author: J. Navarro-Barriuso, et al.
• Optimal response to dimethyl fumarate is mediated by a reduction of Th1‐like Th17 cells after 3 months of treatment.
  Author: M. J. Mansilla, et al.
• Th1Th17CM Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment.
  Author: B. Quirant-Sánchez, et al.
• Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients.
  Author: B. Quirant-Sánchez, et al.
• Collagen analysis with mass spectrometry.
  Author: N. A. van Huizen, et al.
• Identification of a Collagen Marker in Urine Improves the Detection of Colorectal Liver Metastases.
  Author: N. A. van Huizen, et al.
• Early Detection of Growth Hormone Secretagogue Receptor Antagonists Exploiting their Atypical Behavior in Competitive Assays.
  Author: G. M. Danila, et al.
• Affimers as an Alternative to Antibodies in an Affinity LC-MS Assay for Quantification of the Soluble Receptor of Advanced Glycation End-Products (sRAGE) in Human Serum.
  Author: F. Klont, et al.
• Cigarette Smoking Acutely Decreases Serum Levels of the COPD Biomarker sRAGE.
  Author: SD Pouwels, et al.
• Quantification of the soluble Receptor of Advanced Glycation End-Products (sRAGE) by LC-MS after enrichment by strong cation exchange (SCX) solid-phase extraction (SPE) at the protein level.
  Author: F. Klont, et al.
• A fully validated liquid chromatography-mass spectrometry method for the quantification of the soluble receptor of advanced glycation end-products (sRAGE) in serum using immunopurification in a 96-well plate format.
  Author: F. Klont, et al.
• Pre- and Post-analytical Factors in Biomarker Discovery.
  Author: F. Klont, et al.
• Quantification of surfactant protein D (SPD) in human serum by liquidchromatography-mass spectrometry (LC-MS)
  Author: F. Klont, et al.
• Confounding Factors Affecting sRAGE as a Biomarker for Chronic Obstructive Pulmonary Disease
  Author: SD Pouwels, et al.
• Galectin 13 (PP13) Facilitates Remodeling and Structural Stabilization of Maternal Vessels during Pregnancy
  Author: M. Sammar, et al.
• Stratum corneum and systemic biomarkers in infantile AD
  Author: M.A. McAleer, et al.
• Analysis of health-related biomarkers between vegetarians and non-vegetarians: A multi-biomarker approach
  Author: G. Gajski, et al.
• Clinical Proteomics: Closing the Gap from Discovery to Implementation.
  Author: M. Frantzi, et al.
• Systematic review on recent potential biomarkers of chronic obstructive pulmonary disease.
  Author: E. Aydindogan, et al.
• Handbook of Biomarkers and Precision Medicine.
  Author: C. Carini, et al.
• Identification of 4-Hydroxyproline at the Xaa Position in Collagen by Mass Spectrometry.
  Author: NA van Huizen, et al.
• Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics.
  Author: EL van der Ende, et al.
• Neoantigens in Chronic Obstructive Pulmonary Disease and Lung Cancer: A Point of View.
  Author: L. Zeneyedpour, et al.
• The future of protein biomarker research in type 2 diabetes mellitus.
  Author: R. Tans, et al.
• Up-regulation of collagen proteins in colorectal liver metastasis compared with normal liver tissue.
  Author: NA van Huizen, et al.
• Integrated Chemometrics and Statistics to Drive Successful Proteomics Biomarker Discovery.
  Author: A. Suppers, et al.
• Decreased Neuro-Axonal Proteins in CSF at First Attack of Suspected Multiple Sclerosis.
  Author: MP Stoop, et al.
• Immunohistochemistry for predictive biomarkers in non-small cell lung cancer
  Author: M. Mino-Kenudson
• Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies.
  Author: I. Broodman, et. al